- Home
- CWD vs ATNF Comparison
CWD vs ATNF Comparison
Compare CWD & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- ATNF
- Stock Information
- Founded
- CWD 2009
- ATNF 2016
- Country
- CWD United States
- ATNF United States
- Employees
- CWD N/A
- ATNF N/A
- Industry
- CWD Real Estate
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- CWD Finance
- ATNF Health Care
- Exchange
- CWD Nasdaq
- ATNF Nasdaq
- Market Cap
- CWD 4.5M
- ATNF 5.0M
- IPO Year
- CWD 2023
- ATNF N/A
- Fundamental
- Price
- CWD $1.83
- ATNF $7.43
- Analyst Decision
- CWD
- ATNF
- Analyst Count
- CWD 0
- ATNF 0
- Target Price
- CWD N/A
- ATNF N/A
- AVG Volume (30 Days)
- CWD 4.8M
- ATNF 23.1M
- Earning Date
- CWD 08-13-2025
- ATNF 07-23-2025
- Dividend Yield
- CWD N/A
- ATNF N/A
- EPS Growth
- CWD N/A
- ATNF N/A
- EPS
- CWD N/A
- ATNF N/A
- Revenue
- CWD $35,429,000.00
- ATNF N/A
- Revenue This Year
- CWD N/A
- ATNF N/A
- Revenue Next Year
- CWD $31.12
- ATNF N/A
- P/E Ratio
- CWD N/A
- ATNF N/A
- Revenue Growth
- CWD N/A
- ATNF N/A
- 52 Week Low
- CWD $2.20
- ATNF $0.66
- 52 Week High
- CWD $15.80
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- CWD 33.73
- ATNF 65.38
- Support Level
- CWD $2.33
- ATNF $2.94
- Resistance Level
- CWD $2.75
- ATNF $17.46
- Average True Range (ATR)
- CWD 0.76
- ATNF 1.85
- MACD
- CWD -0.05
- ATNF 0.60
- Stochastic Oscillator
- CWD 0.29
- ATNF 32.73
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.